Cargando…
How and When Should NSAIDs Be Used for Preventing Post-ERCP Pancreatitis? A Systematic Review and Meta-Analysis
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to be efficacious to prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). However, the target patients, the type of NSAID, the route of administration and the time of drug delivery remain unclear,...
Autores principales: | Puig, Ignasi, Calvet, Xavier, Baylina, Mireia, Isava, Álvaro, Sort, Pau, Llaó, Jordina, Porta, Francesc, Vida, Francesc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968039/ https://www.ncbi.nlm.nih.gov/pubmed/24675922 http://dx.doi.org/10.1371/journal.pone.0092922 |
Ejemplares similares
-
Prevention of post-ERCP pancreatitis: NSAID or pancreatic stent or both?
por: van Wanrooij, R. L. J., et al.
Publicado: (2019) -
Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis
por: Nawaz, Muhammad Haseeb, et al.
Publicado: (2020) -
Use of NSAIDs via the Rectal Route for the Prevention of Pancreatitis after ERCP in All-Risk Patients: An Updated Meta-Analysis
por: Yu, Lei-Min, et al.
Publicado: (2018) -
The synergistic impact of NSAIDs and aggressive hydration therapy on the rate of post-ERCP pancreatitis in high -risk and low -risk patients
por: Aghajanpoor Pasha, Morteza, et al.
Publicado: (2020) -
Should we incorporate topical epinephrine in the ESGE guideline on prevention of post-ERCP pancreatitis?
por: Toussaint, E., et al.
Publicado: (2020)